Work

FGFR2/3 genomic alterations (GA) in cell-free (cf)DNA from patients (pts) with advanced urothelial carcinoma (aUC).

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.6_suppl.565

Authors: Lesli Ann Kiedrowski, Roby Antony Thomas, Nicholas J. Vogelzang, Guru Sonpavde, Sumati Gupta, Theodore Stewart Gourdin, Bishoy Morris Faltas, Rebecca Nagy, Richard B. Lanman, Petros Grivas

Institutions: Guardant (United States), University of Pittsburgh Medical Center, Comprehensive Cancer Centers of Nevada, Dana-Farber Cancer Institute, Huntsman Cancer Institute, University of Utah Health Care, Medical University of South Carolina, MUSC Hollings Cancer Center, Weill Cornell Medicine, University of Washington

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3007592474

Cites:

Cited by:

Related to: 10